Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Second Ligand/Wyeth-Ayerst SERM to enter clinical trials shortly

March 3, 1999

SuperGen files sNDA for Nipent in mature T-cell malignancies

March 2, 1999

ADIR patents new ellipticine/olivacine derivatives with excellent antitumor activity

March 2, 1999

Onyx and Bayer select lead ras-inhibiting compound

March 2, 1999

MedImmune and Ixsys form alliance for monoclonal antibody development

March 2, 1999

Photofrin approved in Finland

March 1, 1999

Valspodar plus chemotherapy in the treatment of relapsed or refractory AML

March 1, 1999

FDA advisory committee to review another NDA for Temodal in March

March 1, 1999

Magainin awarded SBIR grant for squalamine

March 1, 1999

Matrix begins treating patients in phase II study of FMdC

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...